Results 81 to 90 of about 3,965 (158)

A monoclonal antibody to platelet αIIbβ3 that inhibits protein disulfide isomerase binding and platelet aggregation. [PDF]

Blood Adv
Wang L, Wang J, Li J, Coller BS.
europepmc   +1 more source

Platelets mediate fibrin-induced thromboinflammation and NETosis through a GPVI-polyphosphate-FXIIa procoagulant axis. [PDF]

Blood Vessel Thromb Hemost
Perrot A, Ollivier V, Delbosc S, Zemali F, Rogozarski J, Dupont S, Mazighi M, Camerer E, Kubis N, Jandrot-Perrus M, Ho-Tin-Noé B.   +10 more
europepmc   +1 more source

Aβ₁₋₄₀ Enhances Platelet Sensitivity to Thrombin via NADPH Oxidase-ROS Signaling and Integrin α_IIbβ_₃ Engagement. [PDF]

Biomol Ther (Seoul)
Kim B, Lee BK, Kim JA, Jung YS.
europepmc   +1 more source

Therapeutic Plasma Exchange for Uncontrollable Bleeding After Platelet Inhibition with Ticagrelor: A Report of 2 Cases. [PDF]

Am J Case Rep
Herrmann A, Mai B, Bai Y, Castillo B, Kar B, Klein K, Salas de Armas IA, Salazar E, Tint H, Gregoric ID.   +9 more
europepmc   +1 more source

Eptifibatide: A Pharmacoeconomic Review of its Use in Percutaneous Coronary Intervention and Acute Coronary Syndromes

Eptifibatide (Integrilin(R)) is a selective inhibitor of platelet glycoprotein (GP) IIb/IIIa receptors used as adjunctive therapy for patients undergoing percutaneous coronary intervention (PCI) and for patients with acute coronary syndromes (ACS ...
Greg L. Plosker, Tim Ibbotson
core  

Adjunctive Antithrombotic Medications to Acute Reperfusion Therapy: Current Evidence and Future Directions. [PDF]

Stroke
Menzies LE, Aziz YN, Adeoye O, Broderick JP.   +3 more
europepmc   +1 more source

Spotlight on Eptifibatide in Percutaneous Coronary Intervention and Acute Coronary Syndromes

Eptifibatide (Integrilin(R)) is a selective inhibitor of platelet glycoprotein IIb/IIIa receptors used as adjunctive therapy for patients undergoing percutaneous coronary intervention (PCI) and for patients with acute coronary syndromes (ACS ...
Greg L. Plosker, Tim Ibbotson
core  

αIIbβ3-dependent platelet procoagulant activity promotes pulmonary arterial thrombosis triggered by circulating tissue factor. [PDF]

Thromb Res
Tashbook SE, Kaminski TW, St Croix CM, Watkins SC, Sundd P, Brzoska T.   +5 more
europepmc   +1 more source

Trends in characteristics and outcomes following primary percutaneous coronary intervention: insights from a nationwide analysis. [PDF]

BMC Cardiovasc Disord
Arabi A, AlQahtani A, Arafa S, Tamimi OA, Abujalala S, Khani MA, Ali M, Abdelghani MS, Habib MB, Altermanini M, Singh R, Dros RS, Rafie I, Qintar M, Tamimi HA, Hamid T, AlHijji M, AlSuwaidi J.   +17 more
europepmc   +1 more source

Neutrophil expression of CD41/CD61 complex contributes to their adhesiveness in both healthy individuals and heart failure patients. [PDF]

BMC Immunol
Djouani M, Dumont BL, Neagoe PE, Villeneuve L, Tardif JC, Gagnon D, Racine N, White M, Sirois MG.   +8 more
europepmc   +1 more source